Mymetics Corp. (QB) Stock Price - MYMX

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Mymetics Corp. (QB) MYMX Other OTC Common Stock Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0.003 +10% 0.033 0.033 0.0263 0.03 0.03 16:08:11
Bid Price Ask Price Spread Spread % News
0.022 0.035 0.013 37.14% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
15 250,505 $ 0.0306 $ 7.67k 504.58k 0.02 - 0.10
Last Trade Time Type Quantity Stock Price Currency
15:51:30 5,000 $0.03 USD

Mymetics Corp. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 10.02M 303.76M $ -5.96M - -1.68 91.06M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Mymetics Corp. (QB) News

Latest MYMX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MYMX Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.02850.0330.0221640.028040k325k138k0.004515.79%
1 Month0.02190.0330.0180.023140k439k155k0.011150.68%
3 Months0.050.080.01550.029720k7M507k-0.017-34.00%
6 Months0.034310.0950.01550.046320k7M602k-0.00131-3.82%
1 Year0.0220.0950.0150.043109M454k0.01150.00%
3 Years0.0230.0950.0080.036509M212k0.0143.48%
5 Years0.030.0950.0080.036609M168k0.00310.00%

Mymetics Corp. (QB) Description

Mymetics Corporation is US registered biotechnology company with its main offices in Switzerland and the Netherlands. Focused on developing next generation vaccines for infectious and life threatening diseases. Mymetics core technology and expertise are in the use of virosomes, lipid-based carriers containing functional fusion viral proteins in combination with rationally designed antigens and membrane proteins. Mymetics currently has the following vaccines in its pipeline: HIV/AIDS. intranasal Influenza, RSV, Malaria and Chikungunya.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.